Bibliografia UJ CM

1/7
Fabien Zoulim, Jolanta Białkowska-Warzecha, Mircea Mihai Diculescu, Adrian Eugen Goldis, Renate Heyne, Tomasz Mach, Patrick Marcellin, Jorg Petersen, Krzysztof Simon, Soumaya Bendahmane, Isabelle Klauck, Wojciech Wasiak, Harry L. A. Janssen.
Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure.
Hepatology International
2016 : Vol. 10, nr 5, s. 779-788, il., bibliogr. 35 poz., abstr.
p-ISSN: 1936-0533
AZ
ORG
AIF
IF: 2.164
Adres url:
Streszczenie w PubMed:
2/7
Milan J. Sonneveld, Vincent Rijckborst, Yilmaz Cakaloglu, Krzysztof Simon, E. Jenny Heathcote, Fehmi Tabak, Tomasz Mach, Charles A.B. Boucher, Bettina E. Hansen, Stefan Zeuzem, Harry L.A. Janssen.
Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-Α2b : relation to response and HBV genotype.
Antiviral Therapy
2012 : Vol. 17, nr 1, s. 9-17, bibliogr. 30 poz.
p-ISSN: 1359-6535
AZ
ORG
AIF
IF: 3.073
3/7
Vincent Rijckborsta, Peter Ferenci, Meral Akdogan, Binnur Pinarbasi, Martijn J. ter Borg, Krzysztof Simon, Robert Flisiak, Ulus S. Akarca, Maria Raptopoulou-Gigi, Elke Verhey, Anneke J. Van Vuuren, Charles A. Boucher, Bettina E. Hansen, Harry L.A. Janssen, PARC Study Group.
Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon ?-2a: progressive decrease in hepatitis B surface antigen in responders.
European Journal of Gastroenterology & Hepatology
2012 : Vol. 24, nr 9, s. 1012-1019, il., bibliogr. 21 poz.
p-ISSN: 0954-691X
AZ
ORG
AIF
IF: 1.915
Streszczenie w PubMed:
4/7
Vincent Rijckborst, Martijn J. ter Borg, Yilmaz Cakaloglu, Peter Ferenci, Fehmi Tabak, Meral Akdogan, Krzysztof Simon, Maria Raptopoulou-Gigi, Necati Ormeci, Pieter E. Zondervan, Elke Verhey, Anneke J. Van Vuuren, Bettina E. Hansen, Harry L.A. Janssen, The PARC Study Group.
A randomized trial of peginterferon α-2a with or without ribavirin for HBeAg-negative chronic hepatitis B.
The American Journal of Gastroenterology
2010 : Vol. 105, nr 8, s. 1762-1769, il., bibliogr. 39 poz.,
p-ISSN: 0002-9270
AZ
ORG
AIF
IF: 6.882
5/7
Erik H. C. J. Buster, Hajo J. Flink, Yilmaz Cakaloglu, Krzysztof Simon, Jorg Trojan, Fahmi Tabak, Thomas M.K. So, S. Victor Feinman, Tomasz Mach, Ulus S. Akarca, Martin Schutten, Wanda Telemans, Anneke J. Van Vuuren, Bettina E. Hansen, Harry L.A. Janssen.
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon α-2b.
Gastroenterology
2008 : Vol. 135, nr 2, s. 459-467, il., bibliogr. 30 poz.
p-ISSN: 0016-5085
AZ
ORG
AIF
IF: 12.591
6/7
Monika Zonneveld, van, Pieter E. Zondervan, Yilmaz Cakaloglu, Chrostopher Simon, Ulus S. Akarca, Thomas M.K. So, Hajo J. Flink, Robert A. Man, de, Scholko W. Schalm, Harry L.A. Janssen, HBV 99-01 Study Group.
Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B : No additional benefit of combination with lamivudine.
Liver International
2006 : Vol. 26, nr 4, s. 399-405, il., bibliogr. 16 poz., abstr.
AZ
ORG
AIF
IF: 2.344
7/7
Hajo J. Flink, Bettina E. Hansen, E. Jenny Heathcote, Victor Feinman, Halis Simsek, Selim Karayalcim, Tomasz Mach, Wim F. Leemans, Robert A. de Man, Elke Verhey, Scholko W. Schalm, Harry L.A. Janssen, HBV 99-01 Study Group.
Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine.
The American Journal of Gastroenterology
2006 : Vol. 101, nr 11, s. 2523-2539, il., bibliogr. 17 poz.
AZ
ORG
AIF
IF: 5.608
Adres url:
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ